Real-world Research of Trastuzumab and Pertuzumab Combined with Chemotherapy in Neoadjuvant Treatment of HER2-positive Breast Cancer

Real-world Research of Trastuzumab and Pertuzumab Combined with Chemotherapy in Neoadjuvant Treatment of HER2-positive Breast Cancer

Objective To analyze the efficacy and safety of trastuzumab (H) and pertuzumab (P) combined with different chemotherapy regiments in neoadjuvant therapy for HER2-positive breast cancer. Methods We retrospectively analyzed the clinical data of the patients with HER2-positive breast cancer who receive...

Full description

Bibliographic Details
Main Authors: MA Xiangmin, ZHANG Xiangmei, ZHOU Xinping, REN Xiaofei, ZHANG Weifang, LIU Yunjiang
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-01-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
breast cancer
her2
neoadjuvant therapy
trastuzumab
pertuzumab
pathological complete response
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.0802

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.0802

Similar Items